The development of VIP–ellipticine conjugates
- 15 December 2004
- journal article
- Published by Elsevier in Regulatory Peptides
- Vol. 123 (1-3) , 187-192
- https://doi.org/10.1016/j.regpep.2004.03.021
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- VIP as a trophic factor in the CNS and cancer cellsPeptides, 2003
- VIP-ellipticine derivatives inhibit the growth of breast cancer cellsLife Sciences, 2002
- Cytotoxic agents directed to peptide hormone receptors: Defining the requirements for a successful drugProceedings of the National Academy of Sciences, 1998
- Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathwaysJournal of Molecular Medicine, 1996
- Multiple receptors for PACAP and VIPTrends in Pharmacological Sciences, 1994
- Differential signal transduction by five splice variants of the PACAP receptorNature, 1993
- Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor.Proceedings of the National Academy of Sciences, 1993
- A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth.Proceedings of the National Academy of Sciences, 1993
- Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptideNeuron, 1992
- Polypeptide with Broad Biological Activity: Isolation from Small IntestineScience, 1970